Development of an immunoaffinity solid phase microextraction method for the identification of penicillin binding...

Area of Science:

• Biotechnology
• Analytical Chemistry
• Microbiology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat due to its antibiotic resistance.
• MRSA's resistance is primarily linked to the production of penicillin-binding protein 2a (PBP2a).
• Accurate and sensitive detection methods for PBP2a are crucial for MRSA diagnostics.

Purpose of the Study:

• To develop and characterize antibody-linked immunoaffinity solid phase microextraction (SPME) sorbents for PBP2a identification.
• To determine the binding affinity and efficiency of the developed immunoaffinity sorbents.
• To establish a platform technology for sensitive MRSA detection.

Main Methods:

• Development of antibody-linked immunoaffinity SPME sorbents targeting PBP2a.
• Determination of the on-sorbent binding constant (Kd) using a binding curve analysis.
• Quantification of PBP2a using LC-MS/MS and assessment of surface density.
• Application of bovine serum albumin (BSA) for surface pretreatment to minimize non-specific binding.

Main Results:

• The on-sorbent binding constant (Kd) for the anti-PBP2a antibody and PBP2a antigen was determined to be 4×10⁻¹⁰ M.
• Immunoaffinity sorbents successfully captured PBP2a at concentrations as low as 10 ng/mL.
• Surface density of the antibody was estimated at 59 ng/cm².
• BSA pretreatment effectively reduced non-specific binding of proteins.

Conclusions:

• The developed antibody-linked immunoaffinity SPME sorbents provide a specific and sensitive method for PBP2a detection.
• This platform technology shows promise for the development of practical diagnostic assays for MRSA.
• The findings contribute to advancing in vitro and in vivo diagnostic capabilities for MRSA infections.